Authors:
Kumar, GN
Dykstra, J
Roberts, EM
Jayanti, VK
Hickman, D
Uchic, J
Yao, Y
Surber, B
Thomas, S
Granneman, GR
Citation: Gn. Kumar et al., Potent inhibition of the cytochrome P-450 3A-mediated human liver microsomal metabolism of a novel HIV protease inhibitor by ritonavir: A positive drug-drug interaction, DRUG META D, 27(8), 1999, pp. 902-908
Citation: A. Hsu et al., Ritonavir: clinical pharmacokinetics and interactions with other anti-HIV agents (vol 35, pg 275, 1998), CLIN PHARMA, 35(6), 1998, pp. 473-473
Authors:
Sham, HL
Kempf, DJ
Molla, A
Marsh, KC
Kumar, GN
Chen, CM
Kati, W
Stewart, K
Lal, R
Hsu, A
Betebenner, D
Korneyeva, M
Vasavanonda, S
McDonald, E
Saldivar, A
Wideburg, N
Chen, XQ
Niu, P
Park, C
Jayanti, V
Grabowski, B
Granneman, GR
Sun, E
Japour, AJ
Leonard, JM
Plattner, JJ
Norbeck, DW
Citation: Hl. Sham et al., ABT-378, a highly potent inhibitor of the human immunodeficiency virus protease, ANTIM AG CH, 42(12), 1998, pp. 3218-3224
Citation: Sl. Wong et Gr. Granneman, Modeling of sertindole pharmacokinetic disposition in healthy volunteers in short term dose-escalation studies, J PHARM SCI, 87(12), 1998, pp. 1629-1631